Nuveen Asset Management, LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,163,830
-42.6%
219,177
+3.0%
0.00%
-100.0%
Q2 2023$2,026,993
+177395.0%
212,696
+105.0%
0.00%
Q1 2023$1,142
-26.4%
103,761
-1.0%
0.00%
-100.0%
Q4 2022$1,551
-100.0%
104,786
-80.3%
0.00%
-75.0%
Q3 2022$10,183,000
+32.3%
532,875
+47.6%
0.00%
+33.3%
Q2 2022$7,696,000
+115.7%
361,143
+66.9%
0.00%
+200.0%
Q1 2022$3,568,000
-18.4%
216,380
+2.7%
0.00%0.0%
Q4 2021$4,371,000
-12.1%
210,739
-3.9%
0.00%
-50.0%
Q3 2021$4,973,000
-30.9%
219,392
-16.8%
0.00%0.0%
Q2 2021$7,201,000
+11.6%
263,846
+18.3%
0.00%0.0%
Q1 2021$6,451,000
+26.9%
223,008
+23.5%
0.00%0.0%
Q4 2020$5,082,000
+153.7%
180,642
+164.2%
0.00%
+100.0%
Q3 2020$2,003,000
+50.7%
68,380
+55.6%
0.00%0.0%
Q2 2020$1,329,000
+14.7%
43,955
+13.0%
0.00%0.0%
Q1 2020$1,159,00038,8960.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders